| Cancer Biology and Pharmacology (Master) (with Thesis) | |||||
| Master | TR-NQF-HE: Level 7 | QF-EHEA: Second Cycle | EQF-LLL: Level 7 | ||
| Course Code: | KBY5013 | ||||
| Course Name: | Current Advancements in Cancer Research | ||||
| Semester: | Fall | ||||
| Course Credits: |
|
||||
| Language of instruction: | |||||
| Course Condition: | |||||
| Does the Course Require Work Experience?: | No | ||||
| Type of course: | Departmental Elective | ||||
| Course Level: |
|
||||
| Mode of Delivery: | Face to face | ||||
| Course Coordinator: | Prof. Dr. ENGİN ULUKAYA | ||||
| Course Lecturer(s): | Prof Dr Engin Ulukaya | ||||
| Course Assistants: |
| Course Objectives: | Cancer is a one of the rapidly developing fields of scientific research. At least one new canticancer drug is introduced into the clinics every month. Students are to learnt not only the basic cancer but also translational cancer research topics and new definitions. |
| Course Content: | 1. novel drugs 2. microbiota 3. spheroids 4. organoids 5. in ovo method 6. new hallmarks 7. new cell death modalities 8. nobel-related developments |
|
The students who have succeeded in this course;
1) explain the relationship between microbiota and cancer 2) 2D and 3D cultures should be explained 3) place of spheroids in cancer research should be explained 4) in ovo method should be explained 5) new cell death modalities should be explained 6) tumor chemosensitivity assay should be explained 7) new hallmarks ahould be explained |
| Week | Subject | Related Preparation |
| 1) | microbiota | none |
| 2) | microbiota-2 | none |
| 3) | novel drugs | none |
| 4) | spheroids-1 | none |
| 5) | spheroids-2 | none |
| 6) | organoids | none |
| 7) | in ovo method | none |
| 8) | new hallmarks | none |
| 9) | new hallmarks-2 | none |
| 10) | new cell death modalities | none |
| 11) | new cell death modalities-2 | none |
| 12) | nobel-related issues | none |
| 13) | repeat and missing points | none |
| 14) | prep to exam | none |
| Course Notes / Textbooks: | son 5 yıllık literatür. belli bir ders kitabı yoktur. olamaz da dersin doğası gereği. |
| References: | the literature in the last five years. naturally, there should not be a textbook. |
| Course Learning Outcomes | 1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
|---|---|---|---|---|---|---|---|---|
| Program Outcomes | ||||||||
| 1) The ability to define basic concepts of Cancer Biology and Pharmacology, get information objectively about the related field within the scope of the program | ||||||||
| 2) Having knowledge about the molecular mechanisms of cancer, learning the process of carcinogenesis at molecular level | ||||||||
| 3) Learning of pharmacology and anti-cancer drug development, screening and relevant molecular/cellular techniques (cytotoxicity, etc.), get information about the postgraduate regulation related to cancer research and drug development, cooperation and experience share with institutions providing technological support | ||||||||
| 4) The ability to synthesize, analyze, interpret, interrogate and criticize the relevant information on cancer biology and drug development | ||||||||
| 5) The ability to use good communication skills and computer technology efficiently in their work | ||||||||
| 6) The ability to convey/present the findings of the research and the results either verbally or in writing | ||||||||
| 7) The ability to carry out professional and academic studies independently using accumulated knowledge and to work and take responsibility as a team member with other professions working in this field | ||||||||
| 8) Having a sense of ethical responsibility in research | ||||||||
| No Effect | 1 Lowest | 2 Average | 3 Highest |
| Program Outcomes | Level of Contribution | |
| 1) | The ability to define basic concepts of Cancer Biology and Pharmacology, get information objectively about the related field within the scope of the program | |
| 2) | Having knowledge about the molecular mechanisms of cancer, learning the process of carcinogenesis at molecular level | |
| 3) | Learning of pharmacology and anti-cancer drug development, screening and relevant molecular/cellular techniques (cytotoxicity, etc.), get information about the postgraduate regulation related to cancer research and drug development, cooperation and experience share with institutions providing technological support | |
| 4) | The ability to synthesize, analyze, interpret, interrogate and criticize the relevant information on cancer biology and drug development | |
| 5) | The ability to use good communication skills and computer technology efficiently in their work | |
| 6) | The ability to convey/present the findings of the research and the results either verbally or in writing | |
| 7) | The ability to carry out professional and academic studies independently using accumulated knowledge and to work and take responsibility as a team member with other professions working in this field | |
| 8) | Having a sense of ethical responsibility in research |
| Semester Requirements | Number of Activities | Level of Contribution |
| Attendance | 28 | % 0 |
| Final | 1 | % 100 |
| total | % 100 | |
| PERCENTAGE OF SEMESTER WORK | % 0 | |
| PERCENTAGE OF FINAL WORK | % 100 | |
| total | % 100 | |
| Activities | Number of Activities | Preparation for the Activity | Spent for the Activity Itself | Completing the Activity Requirements | Workload | ||
| Course Hours | 24 | 0 | 0 | ||||
| Final | 1 | 0 | 0 | ||||
| Total Workload | 0 | ||||||